Skip to content

Author

Havva Merve Dinç

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

BAP1 Loss and TFE3 Immunoexpression in High-Grade Clear Cell Renal Cell Carcinoma.

AIMS Native nuclear TFE3 expression occurs in conventional clear cell renal cell carcinoma (ccRCC) lacking TFE3 rearrangement. Because BAP1 loss is associated with mTORC1 activation and metabolic stress that promote MiT/TFE nuclear translocation, we examined whether BAP1 loss is associated with native TFE3 expression i...

M. Oktay, N. A. Yıldırım, H. Dogan et al. · 0 citations
Open access Sep 2026

QUANTITATIVE ASSESSMENT OF P53 IMMUNOHISTOCHEMICAL EXPRESSION IS ASSOCIATED WITH ADVERSE CLINICOPATHOLOGIC FEATURES IN P53 WILD-TYPE ENDOMETRIOID ENDOMETRIAL CARCINOMA

Objective: Endometrioid endometrial carcinoma (EEC) generally has a favorable prognosis, yet some cases exhibit aggressive behavior unexplained by standard parameters. Although p53 immunohistochemistry (IHC) primarily serves as a surrogate for TP53 mutations, quantitative variation within the wild-type (wt) category ma...

S. Kabul, Havva Merve Dinç, M. Ozsen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.